Zheng Xu
Zhejiang TCM Key Laboratory Of Pharmacology And Translational Research Of Natural Products
Hangzhou, 310014, China
Hangzhou, 310014, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Discovery of a covalent FGFR2-selective inhibitor overcoming clinically-acquired resistance mutations.
Journal: Nature communications
Published: December 24, 2025
Cardiomyocytes FGFBP1 induction by STAT3 drives pathological cardiac remodeling.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: December 08, 2025
Lycorine improves inflammatory imbalance in diabetic cardiomyopathy by targeting ILF3.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: September 16, 2025
Taxifolin Attenuates Cisplatin-Induced Acute Kidney Injury by Promoting Fatty Acid Oxidation.
Journal: Journal of biochemical and molecular toxicology
Published: April 07, 2025
Angiotensin II-induced phosphorylation of CHK1 at serine-280 drives cardiac remodelling by direct phosphorylation of JAK1, thus activating JAK1-STAT signalling in murine cardiomyocytes.
Journal: British journal of pharmacology
Published: February 17, 2025
Curcumol Ameliorates Cisplatin-induced Nephrotoxicity by Targeting TAK1 and Inhibiting MAPK and NF-κB Pathways.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: December 16, 2024
Checkpoint kinase Wee1 activation drives inflammation and hypertrophy through the protein kinase B/phosphoinositide 3-kinases-nuclear factor κB pathway in cardiomyocytes.
Journal: European heart journal
Published: July 30, 2024
Showing 1-10 of 10
Last Updated: 09/26/2026